Literature DB >> 4008334

Antitumor activity of leptomycin B.

K Komiyama, K Okada, S Tomisaka, I Umezawa, T Hamamoto, T Beppu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4008334     DOI： 10.7164/antibiotics.38.427

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  11 in total

1.  Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock.

Authors:  I E Gallouzi; C M Brennan; J A Steitz
Journal:  RNA       Date:  2001-09       Impact factor: 4.942

2.  Regulation and function of nuclear IκBα in inflammation and cancer.

Authors:  Ivana Vancurova; Ales Vancura
Journal:  Am J Clin Exp Immunol       Date:  2012-05-25

Review 3.  Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein.

Authors:  Jo Ishizawa; Kensuke Kojima; Numsen Hail; Yoko Tabe; Michael Andreeff
Journal:  Pharmacol Ther       Date:  2015-06-03       Impact factor: 12.310

Review 4.  Atomic basis of CRM1-cargo recognition, release and inhibition.

Authors:  Ho Yee Joyce Fung; Yuh Min Chook
Journal:  Semin Cancer Biol       Date:  2014-03-12       Impact factor: 15.707

Review 5.  Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action.

Authors:  M E Cardenas; M C Cruz; M Del Poeta; N Chung; J R Perfect; J Heitman
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

6.  Protein ligands to HuR modulate its interaction with target mRNAs in vivo.

Authors:  C M Brennan; I E Gallouzi; J A Steitz
Journal:  J Cell Biol       Date:  2000-10-02       Impact factor: 10.539

7.  Epigallocatechin-3-gallate enhances the therapeutic effects of leptomycin B on human lung cancer a549 cells.

Authors:  Meghan M Cromie; Weimin Gao
Journal:  Oxid Med Cell Longev       Date:  2015-04-01       Impact factor: 6.543

Review 8.  Nuclear Export Inhibition for Pancreatic Cancer Therapy.

Authors:  Irfana Muqbil; Asfar S Azmi; Ramzi M Mohammad
Journal:  Cancers (Basel)       Date:  2018-05-07       Impact factor: 6.639

9.  Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone.

Authors:  Irfana Muqbil; Amro Aboukameel; Sivan Elloul; Robert Carlson; William Senapedis; Erkan Baloglu; Michael Kauffman; Sharon Shacham; Divaya Bhutani; Jeffrey Zonder; Asfar S Azmi; Ramzi M Mohammad
Journal:  Cancer Lett       Date:  2016-09-28       Impact factor: 8.679

Review 10.  XPO1-dependent nuclear export as a target for cancer therapy.

Authors:  Nancy G Azizian; Yulin Li
Journal:  J Hematol Oncol       Date:  2020-06-01       Impact factor: 17.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.